Vertex Pharmaceuticals, Inc. VRTX: $207.15

50 Northern Avenue, Boston, MA, US. | Sector: Health Technology | Exchange: NASDAQ | Web: http://www.vrtx.com

Vertex Pharmaceuticals, Inc. (VRTX) Full Financials Data

Gross Profit$1,333,599,000
Cost of Revenue$184,520,000
Operating Revenue$1,518,119,000
Total Revenue$1,518,119,000
Operating Income$720,867,000
Net Income$837,270,000
R & D$420,928,000
Operating Expense$797,252,000
Current Assets$6,694,320,000
Total Assets$10,216,367,000
Total Liabilities$2,697,125,000
Current Cash$4,835,700,000
Current Debt
Short-term Debt
Long-term Debt$522,067,000
Total Cash$5,455,137,000
Total Debt$522,067,000
Shareholder Equity$7,519,242,000
Cash Change$1,233,736,000
Cash Flow$1,038,527,000

Vertex Pharmaceuticals, Inc. (VRTX) Key Stats

Employees3,000
Moving Average (200 Days)$259.02
Moving Average (50 Days)$261.03
Float260,179,965
Avg Volume (10 Days)4,050,282.7
Avg Volume (30 Days)2,141,631.27
EPS TTM$8.0291
Dividend Rate (TTM)
Dividend Yield
Last Dividend Date
PE Ratio25.8
Beta0.848
1 Yr Change 9%
This Yrs' Change -4%
6 Mnths' Change -22%
3 Months' Change-24%
30 Days Change -20%
5 Days Change -4%
Max Change 2547%

Latest News About Vertex Pharmaceuticals, Inc.